Iopidine (Apraclonidine)

Apraclonidine selectively activates alpha‑2 adrenergic receptors in the ciliary body. This activation reduces aqueous humor production and enhances uveoscleral outflow, leading to a decrease in intra‑ocular pressure. Its limited alpha‑1 activity minimizes systemic cardiovascular effects while providing ocular pressure control.

The dosing regimen for Iopidine is determined by the prescribing ophthalmologist based on the patient’s condition and response. Typically, one drop is instilled into the affected eye(s) once or twice daily, but the exact frequency and duration are individualized and should follow the prescriber’s instructions.

Iopidine is classified as pregnancy category C, indicating that risk cannot be ruled out and it should be used only if the potential benefit justifies the potential risk to the fetus. Limited data are available for breastfeeding; therefore, caution is advised and a healthcare professional should be consulted before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Iopidine. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with beta‑blocker eye drops such as timolol, apraclonidine offers a different mechanism by reducing aqueous humor production via alpha‑2 receptor activation, which can be useful when beta‑blockers are contraindicated. It may be used as adjunct therapy or in patients who need an alternative to prostaglandin analogues, but individual response varies.

Iopidine should be stored at temperatures below 25 °C, in its original container, protected from moisture and direct light. The bottle should be kept tightly closed when not in use, and any solution that appears discolored or contains particles should be discarded.

Iopidine is applied topically as an eye drop. The patient should wash hands, tilt the head back, pull down the lower eyelid to create a pocket, and instill one drop into the conjunctival sac of the affected eye(s). The eye should be closed gently for a few seconds to enhance absorption, avoiding blinking or rubbing.

Although uncommon, serious adverse reactions can include severe allergic responses such as angioedema, significant ocular inflammation, corneal edema, or systemic hypotension, especially when used with other systemic alpha‑2 agonists. Patients should seek immediate medical attention if they experience swelling, severe eye pain, vision changes, or signs of low blood pressure.

Iopidine is contraindicated in individuals with known hypersensitivity to apraclonidine or any component of the formulation. It should be used with caution, or avoided, in patients with narrow‑angle glaucoma, severe cardiovascular disease, or those taking systemic alpha‑2 agonists, unless directed by a qualified eye care professional.